Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - P/B ratio
P/B ratio as of April 2024 : 4.74
According to Orchard Therapeutics
's latest financial reports the company has a price-to-book ratio of 4.74.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Orchard Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.66 | 873.87% |
| 2022-12-31 | 0.4783 | -39.38% |
| 2021-12-31 | 0.7890 | -66.84% |
| 2020-12-31 | 2.38 | -46.58% |
| 2019-12-31 | 4.45 | 2.68% |
| 2018-12-31 | 4.34 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.63 | -65.58% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | 0.00% | 🇬🇧 UK |
 Novavax NVAX | -0.7979 | -116.85% | 🇺🇸 USA |
 Novocure
NVCR | 3.75 | -20.90% | Jersey |